Mindray Medical International Limited (NYSE:MR)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of medical devices in China.

Recs

0
Player Avatar NuclearSteve (< 20) Submitted: 12/15/2010 4:24:41 PM : Outperform Start Price: $25.79 MR Score: +12.75

Zacks article

Report this Post Reply

Featured Broker Partners


Advertisement